Wb5, a novel biomarker for monitoring efficacy and success of mass drug administration programs for Wuchereria bancrofti elimination.

Using a subset of Wb-infected samples, preliminary comparative analyses of the efficacy of mWb5-Fc fusion protein in a Luminex platform with the reactivity observed in LIPS demonstrated a highly significant correlation of Wb5 reactivity between the two platforms ( S4 Fig ).

also in 132,142 other papers